Compare MEG & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEG | TLRY |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Canada |
| Employees | 3500 | N/A |
| Industry | Professional Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.8M | 688.9M |
| IPO Year | 2020 | 2018 |
| Metric | MEG | TLRY |
|---|---|---|
| Price | $22.14 | $5.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $35.25 | ★ $72.33 |
| AVG Volume (30 Days) | 219.6K | ★ 7.2M |
| Earning Date | 05-05-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $830,538,000.00 | N/A |
| Revenue This Year | $5.41 | $8.79 |
| Revenue Next Year | $7.19 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.26 | N/A |
| 52 Week Low | $19.04 | $0.36 |
| 52 Week High | $32.00 | $15.70 |
| Indicator | MEG | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 30.70 |
| Support Level | $20.80 | $1.12 |
| Resistance Level | $23.48 | $7.01 |
| Average True Range (ATR) | 0.79 | 0.25 |
| MACD | 0.13 | -0.07 |
| Stochastic Oscillator | 88.92 | 6.20 |
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.